{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Title: Randomised Controlled Trial on Perioperative Oxygen Therapy"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "This randomised controlled trial assessed the effectiveness of perioperative oxygen strategies."
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants undergoing surgery were included based on eligibility criteria, and the study was conducted in a hospital setting."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomised to receive either a high fraction of inspired oxygen or a low fraction."
      },
      "Objective": {
        "score": 1,
        "evidence": "This randomised controlled trial assessed the effectiveness of perioperative oxygen strategies."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the incidence of surgical site infection, measured within 30 days post-surgery."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed using sealed envelopes."
      },
      "Blinding": {
        "score": 3,
        "evidence": "Blinding was applied to outcome assessors, patients, and clinicians."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 200 participants were randomised: 100 to the high oxygen group and 100 to the low oxygen group, between April 2018 and March 2022."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis included 98 participants in the high oxygen group and 97 in the low oxygen group, using an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The high oxygen group showed a slight reduction in surgical site infection (risk ratio 0.91, 95% CI 0.78 to 1.05)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events included increased atelectasis in the high oxygen group (risk ratio 1.47, 95% CI 1.20 to 1.79) and a slight increase in postoperative pulmonary complications (risk ratio 1.06, 95% CI 0.77 to 1.46)."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: PROSPERO CRD42021272361."
      },
      "Funding": {
        "score": 1,
        "evidence": "Funding: National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: NIHR132987)."
      }
    },
    "total_score": 25,
    "max_score": 25
  },
  "model": "gpt-4o"
}